Siemens Healthineers CEO and leadership

Bernhard Montag is a CEO:Healthcare Business at Siemens. He has worked as Head:Marketing at Siemens, Consultant at Siemens, and Mgr:Export Sales at Siemens. Bernd attended Friedrich-Alexander-Universitaet Erlangen-Nuernberg.

Jochen Schmitz is a Member of the Managing Board and CFO at Siemens Healthineers and is based in Erlangen, Bayern, Germany. He has worked as CFO - Siemens Healthcare Imaging & Therapy at Siemens and Corporate Vice President & Controller at Siemens. Jochen attended St. Bernhard Gymnasium and Universitätsklinikum Augsburg between 1988 and 1995.

30 years’ success in regulatory labeling of, public and private payment for, and clinical adoption of therapeutic and diagnostic drugs and devices worldwide, based on diverse and growing skillsets, domain knowledge, and network.Proven skillset includes design and conduct of clinical trials programs from phase I to post-market registries, preparation and presentation of summary reports of safety and efficacy, and leadership of product teams in development and implementation of strategy and tactics vis-à-vis regulators, payers, professional societies, and patient advocates. I am particularly adept at persuasive deployment of clinical and economic evidence to decision-makers and key influencers, credibly asserting the safety, efficacy, reasonableness, necessity, and economic benefits of the product or service. The result has been growth in the appropriate use of novel therapeutic and diagnostic products, alone or in combination.Persuasive deployment of evidence is also evidenced by my success in reforming national barriers to labeling, coverage, and adoption in clinical practice including pilot projects, public-private partnerships, and import-export matters (eg serialization and quality assurance). The result is growth in the capacity of healthcare delivery systems to deliver quality care, broader access by patients in need, and growth of whole markets in the US, Brazil, Chile, India, Canada, China, Central America, and Eastern Europe. The credibility and network accruing to 3 decades’ pursuit of objectives shared among stakeholders in industry, academia, NGOs, and government agencies has facilitated my opinion leadership in clinical evidentiary standards and related matters of government policy.These skillsets, domain knowledge, and networks qualify me to address product-, market-, or delivery system-specific inefficiencies and issues which burden payers and inhibit patients’ access to the benefits of innovation in products and services.